The stock will continue to face pressure as fundamentals deteriorate and the company's strategic pivot to 'consumer fit' and AI has not yet reversed the core business decline. Monitor Q1 2026 for signs of stabilization in submissions and margins.
Price Chart
Executive Summary
GoHealth reported full-year 2025 results with a net loss of $497.8 million, a 6,700% year-over-year deterioration, driven by a $260 million asset impairment charge. Revenue fell 54.7% to $361.8 million as the company intentionally pulled back on Medicare Advantage volume. The stock is down 45% post-earnings.
Key Financial Metrics
Key Facts
- Net loss of $497.8 million in 2025 vs. $7.3 million in 2024
- Revenue declined 54.7% YoY to $361.8 million
- $259.9 million indefinite and long-lived asset impairment charge
- Submissions down 47.4% YoY to 534,657
- Sales per Submission down 14.5% YoY to $668
- Direct Operating Cost per Submission up 2.8% to $594
Financial Impact
Revenue down $437 million, net loss widened by $490.4 million
Risk Factors
- Continued revenue and earnings decline
- Further asset impairments or going concern risk
- Inability to stabilize the Medicare Advantage business
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-022434 |
| Document: goco-20260331.htm | 0001628280-26-022434 |
| Document: 0001628280-26-022434-index-headers.html | 0001628280-26-022434 |
| Document: 0001628280-26-022434-index.html | 0001628280-26-022434 |
| Document: 0001628280-26-022434.txt | 0001628280-26-022434 |
| 8-K Data (Synthetic) | 0001628280-26-022434 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 8, 2026 16w ago | 8-K | $0.3800 $0.3050 | ▲ +19.74% | ▲ +21.85% | — |
Jun 7, 2026 16w ago | Press Release | $0.3800 $0.3050 | ▲ +19.74% | ▲ +21.85% | — |
Mar 31, 2026 26w ago | 8-K | $1.33 $1.05 | ▲ +21.05% | ▲ +24.82% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access